Canada Antitrust Watchdog Rejects Probe Over Drug-Patent Evergreening Tactics
Canada's competition watchdog sent a probe over price gouging by drug companies back to the federal government, suggesting it review the country's current patent laws....To view the full article, register now.
Already a subscriber? Click here to view full article